Bosnia and Herzegovina vs Greece: Percentage of bloodstream infection due to Escherichia coli resistant
Bosnia and Herzegovina
26.8%
in 2022
Greece
24.0%
in 2022
Bosnia and Herzegovina rank
28th
Greece rank
30th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Bosnia and Herzegovina
- Greece
How they compare
Bosnia and Herzegovina currently reports 26.8% against 24.0% in Greece, a difference of 2.8%.
That makes Bosnia and Herzegovina's figure about 1.1 times Greece's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 28th and Greece ranks 30th of 50 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.8% | 19.8% | 2.0% | Bosnia and Herzegovina |
| 2020s | 26.4% | 23.5% | 2.9% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Bosnia and Herzegovina or Greece?
- Bosnia and Herzegovina, at 26.8% against 24.0% in Greece as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Bosnia and Herzegovina and Greece?
- 2.8%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Greece?
- 6 years are reported by both, from 2017 to 2022.
- How do Bosnia and Herzegovina and Greece rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Bosnia and Herzegovina ranks 28th and Greece ranks 30th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.